Merck KGaA (MKGAF)
OTCMKTS · Delayed Price · Currency is USD
138.07
+7.22 (5.52%)
Oct 31, 2025, 4:00 PM EDT
Merck KGaA Market Cap
Merck KGaA has a market cap or net worth of $56.89 billion as of October 31, 2025. Its market cap has decreased by -25.29% in one year.
Market Cap
56.89B
Enterprise Value
66.00B
Revenue
24.92B
Ranking
n/a
PE Ratio
16.92
Stock Price
$138.07
Market Cap Chart
Since April 7, 1997, Merck KGaA's market cap has increased from 6.76B to 56.89B, an increase of 741.30%. That is a compound annual growth rate of 7.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 56.89B | -9.85% |
| Dec 30, 2024 | 63.11B | -8.87% |
| Dec 29, 2023 | 69.25B | -17.61% |
| Dec 30, 2022 | 84.06B | -24.78% |
| Dec 30, 2021 | 111.75B | 49.03% |
| Dec 30, 2020 | 74.98B | 45.94% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 648.67M |
| Glass House Brands | 563.30M |
| Northwest Biotherapeutics | 355.88M |
| Silence Therapeutics | 341.50M |
| Nika Pharmaceuticals | 312.10M |
| CytoDyn | 303.60M |
| American Oncology Network | 297.14M |